Cocrystal Pharma, Inc. (COCP)
1.21
+0.07
(+6.14%)
USD |
NASDAQ |
Sep 18, 16:00
1.23
+0.02
(+1.65%)
Pre-Market: 20:00
Cocrystal Pharma Net Income (TTM) : -9.938M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -9.938M |
| March 31, 2026 | -8.829M |
| December 31, 2025 | -8.831M |
| September 30, 2025 | -9.671M |
| June 30, 2025 | -12.56M |
| March 31, 2025 | -15.85M |
| December 31, 2024 | -17.50M |
| September 30, 2024 | -18.70M |
| June 30, 2024 | -17.93M |
| March 31, 2024 | -16.75M |
| December 31, 2023 | -17.98M |
| September 30, 2023 | -18.02M |
| June 30, 2023 | -19.56M |
| March 31, 2023 | -39.82M |
| December 31, 2022 | -38.84M |
| September 30, 2022 | -38.02M |
| June 30, 2022 | -36.26M |
| March 31, 2022 | -15.66M |
| December 31, 2021 | -14.18M |
| September 30, 2021 | -11.99M |
| June 30, 2021 | -10.72M |
| March 31, 2021 | -10.40M |
| December 31, 2020 | -9.648M |
| September 30, 2020 | -56.00M |
| June 30, 2020 | -55.11M |
| Date | Value |
|---|---|
| March 31, 2020 | -53.13M |
| December 31, 2019 | -48.17M |
| September 30, 2019 | -44.61M |
| June 30, 2019 | -44.70M |
| March 31, 2019 | -44.53M |
| December 31, 2018 | -49.05M |
| September 30, 2018 | 0.133M |
| June 30, 2018 | -0.259M |
| March 31, 2018 | 0.082M |
| December 31, 2017 | -0.913M |
| September 30, 2017 | -71.56M |
| June 30, 2017 | -71.18M |
| March 31, 2017 | -73.41M |
| December 31, 2016 | -74.87M |
| September 30, 2016 | -39.57M |
| June 30, 2016 | -38.20M |
| March 31, 2016 | -37.59M |
| December 31, 2015 | -50.12M |
| September 30, 2015 | -21.58M |
| June 30, 2015 | -23.62M |
| March 31, 2015 | -16.27M |
| December 31, 2014 | -0.098M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| CNBX Pharmaceuticals, Inc. | -0.4621M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 9.30M |
| Fulcrum Therapeutics, Inc. | -85.00M |
| Definium Therapeutics, Inc. | -353.78M |